Furthermore, the study suggests a role of IAP as a biomarker for diagnosing any possible IAP deficiency-mediated pathogenesis of “the incipient metabolic syndrome” including “incipient IHD.” The gene discussed is ALPI; the disease is metabolic syndrome.